It only takes a little research to understand why investors might get excited about investing in Aurora Cannabis (NYSE:ACB). The bullish case for ACB stock really starts and ends with two simple words: addressable market.
Cannabis businesses will live or die based on whether they can build consumer trust. If customers don’t trust what you’re selling or aren’t sure about your brand, they’re not going to buy from you. But if you can establish a strong baseline of brand trust, you may be able to develop flourishing customer relationships that last indefinitely.
Why is trust so important, and how can you achieve higher levels of trust in your cannabis business?
A couple of months ago, I discussed several reasons to be bullish on cannabis stocks, including soaring demand, a potentially friendlier federal government and a likely increase in the number of states legalizing cannabis for adult-use. Since then, demand has remained robust in both newer markets out East and more mature markets in the West.
Nebraska’s Supreme Court has removed the state’s medical cannabis initiative from the November ballot following a legal challenge by the Lancaster County Sheriff.
Earlier than normal cold conditions could result in lots of loss flower for farmers.
An early cold snap that swept through Colorado on Tuesday and into Wednesday drove temperatures below freezing and dumped inches of snow, potentially destroying millions of dollars worth of outdoor cannabis and hemp plants.
While the coronavirus pandemic has caused the collapse of retail businesses across the globe, there is one thing people have been buying more of during months of lockdown: marijuana.
The legal cannabis industry set sales records across the United States and Canada over the past six months, according to cannabis analytics firm New Frontier Data, which partially attributed the market’s growth to the COVID-19 outbreak.
“The evolving retail arena is increasingly competitive and requires rapid innovation,” – Cannapreneur Partners Co-CEO Todd Sullivan.
Cannabis vending machines have been gaining ground in the U.S. and Canadian markets.
In 2014, Vancouver dispensary B.C. Pain Society installed what is believed to be the first assistant-less vending option. Since then, other Canadian operations and legal U.S. markets have followed suit.
They argue legalization is a racial justice issue, but critics question the timing in the midst of a pandemic and high-stakes presidential contest.
Democrats are taking an unprecedented gamble this month: voting to legalize cannabis at the federal level.
The MORE Act would remove the penalties for marijuana, erase some criminal records and create grant programs for people hit especially hard by the war on drugs.
To quote Kenneth Morrow in his piece “What to do with Surplus Cannabis” from Cannabis Business Times' August 2020 issue:
Over the past few years, cannabis has been increasingly accepted into the mainstream as an effective therapy that can produce fewer side effects than other prescription drugs in many patients. This acceptance is reflected in the rapid evolution in legislation surrounding cannabis around the world.
However, due to current regulations, pharmacies in Canada are limited to dispensing medical cannabis via online channels. On a larger scale, even other countries where cannabis has been legalized for therapeutic purposes may be limited in their methods of legally distributing the drug.
